Margaret Ellen Macy
Physician at 16 Ave, Denver, CO

License number
Colorado 42587
Issued Date
May 10, 2004
Renew Date
May 1, 2015
Expiration Date
Apr 30, 2017
Type
Physician
Address
Address
13123 E 16Th Ave, Denver, CO 80045

Personal information

See more information about Margaret Ellen Macy at radaris.com
Name
Address
Phone
Margaret Macy
8967 Wagner Ln, Westminster, CO 80031
Margaret Macy
2248 Black Duck Ave, Johnstown, CO 80534
Margaret Macy
221 S Garfield St UNIT 206, Denver, CO 80209
Margaret Macy
4839 Mt Cameron Dr, Brighton, CO 80601
Margaret Macy
221 Garfield St, Denver, CO 80209

Professional information

Margaret Macy Photo 1

Margaret Macy, Aurora CO

Specialties:
Pediatric Hematologist / Oncologist
Address:
13123 E 16Th Ave, Aurora, CO 80045
Education:
Case Western Reserve University, School of Medicine - Doctor of Medicine
Board certifications:
American Board of Pediatrics Certification in Pediatrics, American Board of Pediatrics Sub-certificate in Pediatric Hematology/Oncology (Pediatrics)


Margaret E Macy Photo 2

Dr. Margaret E Macy, Aurora CO - MD (Doctor of Medicine)

Age:
48
Address:
13123 E 16Th Ave, Aurora 80045
(720) 777-6740 (Phone)
7720 S Broadway SUITE 1, Littleton 80122
(720) 777-6740 (Phone)
Hospitals:
13123 E 16Th Ave, Aurora 80045
7720 S Broadway SUITE 1, Littleton 80122
University Hospital
234 Goodman St, Cincinnati 45219
Education:
Medical Schools
Case Western Reserve University School Of Medicine
Graduated: 2002


Margaret Macy Photo 3

Methods Of Leukemia Cell Detection

US Patent:
2012006, Mar 15, 2012
Filed:
Apr 19, 2010
Appl. No.:
13/264943
Inventors:
Lia Gore - Denver CO, US
Deborah Deryckere - Boulder CO, US
Margaret E. Macy - Denver CO, US
Natalie Serkova - Denver CO, US
Assignee:
THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE - Denver CO
International Classification:
A61K 49/06, A61K 47/00, C12Q 1/02
US Classification:
424 93, 435 29, 514789
Abstract:
Methods are provided for, inter alia, determining the presence of leukemia cells in a subject, determining the change or potential change in the number of leukemia cells in the subject with time, determining whether a tissue in a subject contains a plurality of leukemia cells or a plurality progenitor leukemia cells, and determining whether a leukemia therapy administered to a subject is capable of decreasing the number of leukemia cells in a tissue of the subject.